ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
Clinical trial NCT05830123 · RECRUITING
Trial details
- NCT number
- NCT05830123
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-08
- Primary completion
- 2025-12-31
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.